Page last updated: 2024-08-24

fluorexon and Bone Cancer

fluorexon has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, P; Junger, WG; Qi, B; Sun, D; Wang, C; Wang, T; Xia, Y; Yao, J; Yu, T; Zhang, X	1

Other Studies

1 other study(ies) available for fluorexon and Bone Cancer

Article	Year
Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate. Journal of experimental & clinical cancer research : CR, 2016, 10-03, Volume: 35, Issue:1 Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracorporeal Shockwave Therapy; Fluoresceins; Humans; Methotrexate; Osteosarcoma; Receptors, Purinergic P2X7	2016

Article

Year

Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate.

Journal of experimental & clinical cancer research : CR, 2016, 10-03, Volume: 35, Issue:1

Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracorporeal Shockwave Therapy; Fluoresceins; Humans; Methotrexate; Osteosarcoma; Receptors, Purinergic P2X7

2016